DSE Escape Room at ASH
Best Orphan Product Marketing Initiative
In 2019, EUSA Pharma set out on a mission to raise awareness about a rare disease called idiopathic multicentric Castleman disease (iMCD) and its recommended treatment: SYLVANT® (siltuximab). It’s a true puzzle to diagnose, as iMCD can mimic other conditions like cancer and autoimmune diseases.
Educate HCPs on the true diagnostic riddle of iMCD at one of the largest medical conferences in the world.
There’s no better way to show doctors how puzzling the diagnosis of iMCD can be than to let them solve the puzzle themselves.
We created a real-life puzzle—an escape room—based on the iMCD patient journey to guide doctors through the diagnostic process.
~ Edward de Bono